Latest Security News

AustChina Holdings has raised $1.5 million through a private placement with Bluestone Energy, aiming to accelerate acquisitions and exploration across its energy and mineral projects.

Island Pharmaceuticals has engaged a top Washington DC government affairs firm to accelerate its US biodefence strategy, focusing on its antiviral drug Galidesivir amid promising FDA regulatory signals.

DroneShield Limited has clarified the recent exercise and sale of shares by its directors following performance option vesting, alongside addressing an erroneous contract announcement that was later withdrawn. The company also outlined steps to enhance compliance with ASX continuous disclosure and trading policies.

Stakk Limited has secured a strategic multi-year partnership with Stride Bank, a 110-year-old U.S. institution, further accelerating its annualised recurring revenue and broadening its footprint across American financial sectors.

Stealth Group Holdings has explained the late filing of a director’s interest notice as an administrative oversight, assuring no market harm occurred. The company has since strengthened its compliance controls to prevent future lapses.

West Wits Mining has secured an initial US$12.5 million drawdown from its US$35 million Nebari facility, powering development at its Qala Shallows Gold Project in South Africa. The company reports key operational milestones, including first underground ore delivery and fleet expansion, targeting first gold pour by March 2026.

Askari Metals Limited’s AS2OC securities have been suspended from trading pending compliance with ASX Listing Rule 2.5, raising questions about the company’s regulatory standing.

Ava Risk Group announces the upcoming retirement of CEO Mal Maginnis, with senior executive Neville Joyce appointed as Acting CEO. The company embarks on a global search for a permanent replacement amid strong recent growth.

EOS has bolstered its counter-drone arsenal by acquiring a UK-based interceptor business and securing a landmark €71.4 million export contract for its 100kW high energy laser system with The Netherlands.

Qube Holdings reported a robust FY25 with significant revenue and earnings growth, strategic acquisitions, and a refreshed board leadership. Despite operational challenges, the company raised its dividend and confirmed solid FY26 earnings guidance.

Orthocell Limited reports growing adoption of its Remplir™ nerve repair product in nerve-sparing prostate cancer surgeries across Australia, positioning for a significant U.S. market expansion. The company is investing in research and commercial infrastructure ahead of a medium-term U.S. launch.

CVC Limited has released a replacement prospectus for its $75 million CVC Notes 3 offer, combining a New Money Offer and a Reinvestment Offer for existing CVCHA holders. The notes aim to support CVC’s capital management and real estate investment strategy.